Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan J Garber

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 27, 2019
LETTER TO THE EDITORAlan J Garber
American Family Physician|March 2, 2006
New standards to reduce morbidity and mortality in hospitalized patients with diabetesAlan J Garber
Clinical Therapeutics|March 8, 2006
Assessing the role of biphasic insulin aspart 30 as an effective and tolerable front-line therapy for type 2 diabetesAlan J Garber
Diabetes Care|October 31, 2009
Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapyAlan J Garber
The Lancet. Diabetes & Endocrinology|April 8, 2014
GLP-1 receptor agonists: why is once weekly inferior to once daily?Alan J Garber
Heart Failure Clinics|September 25, 2012
Postprandial dysmetabolism and the heartAlan J Garber
Diabetes, Obesity & Metabolism|October 13, 2005
Pharmacologic modifications of hormones to improve their therapeutic potential for diabetes managementAlan J Garber
The Medical Clinics of North America|August 17, 2004
The metabolic syndromeAlan J Garber
The Review of Diabetic Studies : RDS|January 21, 2012
Incretin therapy--present and futureAlan J Garber
The Journal of the American Osteopathic Association|August 5, 2011
Novel incretin-based agents and practical regimens to meet needs and treatment goals of patients with type 2 diabetes mellitusAlan J Garber
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 27, 2019
LETTER TO THE EDITORAlan J Garber
American Family Physician|March 2, 2006
New standards to reduce morbidity and mortality in hospitalized patients with diabetesAlan J Garber
Clinical Therapeutics|March 8, 2006
Assessing the role of biphasic insulin aspart 30 as an effective and tolerable front-line therapy for type 2 diabetesAlan J Garber
Diabetes Care|October 31, 2009
Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapyAlan J Garber
The Lancet. Diabetes & Endocrinology|April 8, 2014
GLP-1 receptor agonists: why is once weekly inferior to once daily?Alan J Garber
Heart Failure Clinics|September 25, 2012
Postprandial dysmetabolism and the heartAlan J Garber
Diabetes, Obesity & Metabolism|October 13, 2005
Pharmacologic modifications of hormones to improve their therapeutic potential for diabetes managementAlan J Garber
The Medical Clinics of North America|August 17, 2004
The metabolic syndromeAlan J Garber
The Review of Diabetic Studies : RDS|January 21, 2012
Incretin therapy--present and futureAlan J Garber
The Journal of the American Osteopathic Association|August 5, 2011
Novel incretin-based agents and practical regimens to meet needs and treatment goals of patients with type 2 diabetes mellitusAlan J Garber
Pageof 10